The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 569-575

  Rohatgi, Anand ^a   Ayers, Colby R ^a   Khera, Amit ^a   McGuire, Darren K ^a   Das, Sandeep R ^a   Matulevicius, Susan ^a   Timaran, Carlos H ^b   Rosero, Eric B ^b   de Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Coronary disease; Dallas Heart Study; Inflammation; Peptidoglycan; Peripheral vascular disease

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; PEPTIDOGLYCAN; PEPTIDOGLYCAN RECOGNITION PROTEIN 1; SYNAPSIN I; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL ATHEROSCLEROSIS; PHENOTYPE; POPULATION; PRIORITY JOURNAL; PROBABILITY;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PEPTIDOGLYCAN; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 62649148802     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.07.015     Document Type: Article

References (33)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Johnston S.C., Zhang H., Messina L.M., Lawton M.T., and Dean D. Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum. Arterioscler Thromb Vasc Biol 25 (2005) 2648-2653
3. Cho J.H., Fraser I.P., Fukase K., et al. Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. Blood 106 (2005) 2551-2558
4. Schrijver I.A., De Man Y.A., Melief M.J., et al. Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients. Clin Exp Immunol 123 (2001) 140-146
5. Schrijver I.A., Melief M.J., Markusse H.M., et al. Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects. Rheumatology (Oxford) 40 (2001) 438-446
6. Wang J.E., Jorgensen P.F., Almlof M., et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 68 (2000) 3965-3970
7. Guan R., and Mariuzza R.A. Peptidoglycan recognition proteins of the innate immune system. Trends Microbiol 15 (2007) 127-134
8. Royet J., and Dziarski R. Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences. Nat Rev Microbiol 5 (2007) 264-277
9. Victor R.G., Haley R.W., Willett D.L., et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93 (2004) 1473-1480
10. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
11. Jain T., Peshock R., McGuire D.K., et al. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol 44 (2004) 1011-1017
12. Jaffer F.A., O'Donnell C.J., Larson M.G., et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol 22 (2002) 849-854
13. Drazner M.H., Dries D.L., Peshock R.M., et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension 46 (2005) 124-129
14. Erlandsen E.J., Randers E., and Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59 (1999) 1-8
15. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
16. Abdullah S.M., Khera A., Das S.R., et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 96 (2005) 1284-1289
17. Deo R., Khera A., McGuire D.K., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44 (2004) 1812-1818
18. de Lemos J.A., Zirlik A., Schonbeck U., et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 25 (2005) 2192-2196
19. Abedin M., Omland T., Ueland T., et al. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol 99 (2007) 513-518
20. Abdullah S.M., Khera A., Leonard D., et al. Sex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 195 (2007) 404-410
21. Long J. Regression models for categorical and limited dependent variables (1997), Sage
22. Zirlik A., Abdullah S.M., Gerdes N., et al. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 2043-2049
23. Laman J.D., Schoneveld A.H., Moll F.L., van Meurs M., and Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol 90 (2002) 119-123
24. Nijhuis M.M., van der Graaf Y., Melief M.J., et al. IgM antibody level against proinflammatory bacterial peptidoglycan is inversely correlated with extent of atherosclerotic disease. Atherosclerosis 173 (2004) 245-251
25. Kang D., Liu G., Lundstrom A., Gelius E., and Steiner H. A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc Natl Acad Sci USA 95 (1998) 10078-10082
26. Liu C., Gelius E., Liu G., Steiner H., and Dziarski R. Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J Biol Chem 275 (2000) 24490-24499
27. Budoff M.J., Georgiou D., Brody A., et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 93 (1996) 898-904
28. Rumberger J.A., Schwartz R.S., Simons D.B., et al. Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy. Am J Cardiol 73 (1994) 1169-1173
29. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., and Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92 (1995) 2157-2162
30. Schmermund A., Baumgart D., Görge G., et al. Measuring the effect of risk factors on coronary atherosclerosis: coronary calcium score versus angiographic disease severity. J Am Coll Cardiol 31 (1998) 1267-1273
31. Berenson G.S., Wattigney W.A., Tracy R.E., et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol 70 (1992) 851-858
32. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY study. Arterioscler Thromb: J Vasc Biol 13 (1993) 1291-1298
33. Cook N.R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115 (2007) 928-935